The gapmer, tested at multiple doses, exhibited a maximal efficacy on intranuclear foci reduction and DMPK mRNAs expression at 500nM in DM1 hiPSC-derived neural stem cells. Here, DMPK is linked to myotonic dystrophy type 1.